PHPierre C. Havugimana

Pierre C. Havugimana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pierre C. Havugimana has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Progressive Remodeling of Global Protein Interaction Networks in a Mouse Model of Tauopathy

    by Weiwei Lin, Sadhna Phanse, Sophie J.F. van der Spek, Noah Lampl, Morgan C. Stephens, Alejandro Rondon Ortiz, Alexandria Taylor, Ryan Hekman, Rebecca Roberts, Lulu Jiang, et al.

    SUMMARY: Neurodegenerative disease is marked not just by loss of proteins or cells, but by dynamic rewiring of macromolecular interaction networks that precede and drive pathology. Here, we present the first temporally resolved, systems-scale map of multi-protein complex remodeling in a tauopathy model, integrating co-fractionation mass spectrometry, quantitative phosphoproteomics, and machine learning to decode phosphorylation-dependent shifts in protein interactomes across disease progression. This interactomic atlas identifies functionally validated assemblies—including MAPT-Dpysl2 and Cyfip1-actin complexes—that modulate early disease phenotypes in vivo. By revealing how phosphorylation tunes macromolecular complex architecture and function, this work reframes tauopathy as a disease of dynamic network instability, and establishes a generalizable framework for early detection and mechanistic dissection of neurodegeneration.


  • Top Cited Papers
    Open Access

    The protein organization of a red blood cell

    by Wisath Sae-Lee, Caitlyn L. McCafferty, Eric J. Verbeke, Pierre C. Havugimana, Ophelia Papoulas, Claire D. McWhite, John R. Houser, Kim Vanuytsel, George J. Murphy, Kevin Drew, et al.


  • Open Access

    The protein organization of a red blood cell

    by Wisath Sae-Lee, Caitlyn L. McCafferty, Eric J. Verbeke, Pierre C. Havugimana, Ophelia Papoulas, Claire D. McWhite, John R. Houser, Kim Vanuytsel, George J. Murphy, Kevin Drew, et al.

    SUMMARY: Red blood cells (RBCs, erythrocytes) are the simplest primary human cells, lacking nuclei and major organelles, and instead employing about a thousand proteins to dynamically control cellular function and morphology in response to physiological cues. In this study, we defined a canonical RBC proteome and interactome using quantitative mass spectrometry and machine learning. Our data reveal an RBC interactome dominated by protein homeostasis, redox biology, cytoskeletal dynamics, and carbon metabolism. We validated protein complexes through electron microscopy and chemical crosslinking, and with these data, built 3D structural models of the ankyrin/Band 3/Band 4.2 complex that bridges the spectrin cytoskeleton to the RBC membrane. The model suggests spring-link compression of ankyrin may contribute to the characteristic RBC cell shape and flexibility. Taken together, our study provides an in-depth view of the global protein organization of human RBCs and serves as a comprehensive resource for future research.


  • Open Access

    BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain

    by Reza Pourhaghighi, Peter E.A. Ash, Sadhna Phanse, Florian Goebels, Lucas Z.M. Hu, Siwei Chen, Yingying Zhang, Shayne D. Wierbowski, Samantha Boudeau, Mohamed T. Moutaoufik, et al.


  • Extracellular histones identified in crocodile blood inhibit in-vitro HIV-1 infection

    by Hannah N. Kozlowski, Eric T.L. Lai, Pierre C. Havugimana, Carl White, Andrew Emili, Darinka Sakac, Beth Binnington, Anton Neschadim, Stephen D.S. McCarthy, Donald R. Branch

    Objective: It has been reported that crocodile blood contains potent antibacterial and antiviral properties. However, its effects on HIV-1 infection remain unknown. Design: We obtained blood from saltwater crocodiles to examine whether serum or plasma could inhibit HIV-1 infection. We purified plasma fractions then used liquid chromatography–mass spectrometry to identify the inhibitory protein factor(s). We then analyzed the ability of recombinant proteins to recapitulate HIV-1 inhibition and determine their mechanism of action. Methods: Crocodylus porosus plasma was tested for inhibition of Jurkat T-cell HIV-1 infection. Inhibitor(s) were purified by reverse-phase chromatography then identified by protein liquid chromatography–mass spectrometry. Anti-HIV-1 activity of purified plasma or recombinant proteins were measured by p24 enzyme-linked immunosorbent assay and luciferase readouts, and mechanism of action was determined by measuring HIV-1 RNA, cDNA and transcription (using 1G5 cells). Results: Crocodile plasma contains potent inhibitors of HIV-1IIIB infection, which were identified as histones. Recombinant human histones H1 and H2A significantly reduced HIV-1JR-FL infection (IC50 of 0.79 and 0.45 μmol/l, respectively), whereas H4 enhanced JR-FL luciferase activity. The inhibitory effects of crocodile plasma, recombinant H1 or recombinant H2A on HIV-1 infection were during or post-viral transcription. Conclusion: Circulating histones in crocodile blood, possibly released by neutrophil extracellular traps, are significant inhibitors of HIV-1 infection in-vitro. Extracellular recombinant histones have different effects on HIV-1 transcription and protein expression and are downregulated in HIV-1 patients. Circulating histones may be a novel resistance factor during HIV-1 infection, and peptide versions should be explored as future HIV-1 therapeutics that modulate viral transcription.